High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorKaohsiung Medical University Chung-Ho Memorial Hospital
About this trial
High-intensity laser therapy has gained increasing attention in recent years as a therapeutic modality. It is a non-invasive treatment that can reduce pain, increase local blood circulation, and promote tissue repair. The higher energy output of high-intensity laser therapy also have deeper tissue penetration. Several studies have investigated the effects of high-intensity laser therapy on lateral epicondylitis, and the existing literature indicates that, compared with other treatment modalities, high-intensity laser therapy is more effective in improving pain and quality of life in patients with lateral epicondylitis.
However, the dosage, duration, and treatment frequency applied in previous studies vary considerably. The therapeutic effects of high-intensity laser therapy may therefore be influenced by treatment dosage. Consequently, the purpose of this study is to compare the effects of two different dosages of high-intensity laser therapy on patients with lateral epicondylitis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients diagnosed with lateral epicondylitis by physician
Disease duration of less than three months
Adults aged above 18 years with full decision-making capacity
Disqualifiers
Patients who have received treatments other than standard treatment to the affected area within past three months
Patients with contraindication for rehabilitation therapy
Photosensitivity
Sensory impairment
Trial design
Design model
Parallel
Treatments tested in this trial
High intensity laser therapy
DeviceUsing high-intensity laser therapy applying on the affected area.
Infarred ray therapy system
DeviceUsing infarred ray therapy applying on affected area for 15 minutes.
Transcutaneous electrical nerve stimulator
DeviceUsing transcutaneous electrical nerve stimulator on the affected area fior 15 minutes.
Treatment groups
45 Participants
are divided into 3 treatment groupsGroup A: Conrol groupPlacebo comparator 2 interventions
Group B: Low dosage groupExperimental treatment 3 interventions
Group C: High dosage groupExperimental treatment 3 interventions
Trial outcomes
Primary outcomes
1
Pain intensity
Using visual analog scale to measure pain intensity. Score from 0 to 10. Score 0 means no pain and score 10 indicates highest pain.
Time frame
From enrollment to the end of treatment at 4 weeksSecondary outcomes
1
Grip strength
Using dynanometer to measure grip strength
Time frame
From enrollment to the end of treatment at 4 weeks2
Quality of life
Using Quick disabilities of the Arm, Shoulder, and hand scale (also known as Quick DASH) to measure quality of life of participants. Scale contains 11 questions. Each question scored from 1 to 5, higher score indicates higher degree of disability.
Time frame
From enrollment to the end of treatment at 4 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov